Healthcare / Health Information ServicesShenzhen
$10.22
-0.35 (-3.31%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $5.0M · quality 48.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
31/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.5B
P/E
340.7x
↑EV/EBITDA
78.2x
↑ROE
0.9%
↑Gross Margin
30.4%
↓Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-11.9%
FCF CAGR
-57.5%
FCF margin
1.7%
FCF / Net income
0.54x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $298.1M · net income $9.3M · FCF $5.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $298.1M | $298.1M | $379.1M | $459.6M | $436.6M |
| Net Income | $9.3M | $9.3M | $-512.1M | $77.5M | $70.3M |
| EBITDA | $37.5M | $37.5M | $-478.7M | $128.1M | $108.9M |
| EPS | 0.03 | 0.03 | -1.52 | 0.23 | 0.21 |
| Gross Margin | 30.4% | 30.4% | 33.3% | 39.0% | 37.8% |
| Operating Margin | -3.8% | -3.8% | 7.6% | 17.5% | 14.1% |
| Net Margin | 3.1% | 3.1% | -135.1% | 16.9% | 16.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 |
| Current Ratio | 1.90 | 1.90 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $5.0M | $5.0M | $32.8M | $-7.1M | $65.5M |
| Returns | |||||
| ROE | 0.9% | 0.9% | -47.4% | 4.8% | 4.6% |
| Valuation | |||||
| P/E | 340.67 | 340.67 | — | 67.39 | 53.10 |
| EV/EBITDA | 78.24 | 78.24 | — | 38.78 | 31.73 |
| P/B | 2.94 | 2.94 | 4.19 | 3.24 | 2.43 |
| Growth & Yield | |||||
| Revenue Growth | -21.4% | -21.4% | -17.5% | 5.3% | — |
| EPS Growth | 102.0% | 102.0% | -760.9% | 9.5% | — |
| Dividend Yield | 0.7% | 0.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
211.5%
EPS terminal req.
$0.91
Spread vs growth
-109.5%
5Y implied EPS CAGR
105.4%
EPS terminal req.
$1.10
Spread vs growth
-3.4%
10Y implied EPS CAGR
50.3%
EPS terminal req.
$1.77
Spread vs growth
51.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-27.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.52 → 0.03
Residual
-28.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.